Skip to main content

Security report for alopharm.com

Alopharm · Healthcare · Latvia

High risk. 10 critical or high findings in SSL/TLS, Network security and 2 other checks.

Security score

33/100

Risk levelHigh

0–100, higher is better. How it is calculated

Alopharm is a healthcare-related company with a website built on WordPress, providing information about its services, team, compliance, and international presence. The site targets healthcare professionals and partners, positioning itself as a niche regional player with a small company size. The website content is basic and primarily informational, with limited interactive features or detailed business disclosures. Technically, the site uses standard web technologies including WordPress CMS and Google Fonts, but lacks advanced SEO and accessibility features. Security posture is minimal with no detected security headers or privacy policies, and the site uses HTTPS though SSL configuration details are unknown. No forms or tracking scripts are present, indicating minimal user data collection. Overall, the site is functional but lacks comprehensive privacy, security, and compliance measures, which could impact trust and regulatory adherence.

Scanned

NIS2 and GDPR posture

GDPR outside view
35/ 100 · High
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

10 findings rated critical or high. Fix these first.

  1. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • Critical

      Unable to retrieve SSL certificate

      Could not establish secure connection to retrieve certificate information

      What to do: Check if the server is accessible and SSL/TLS is properly configured

  2. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • Critical

      Critical Service Exposed: MySQL

      Port 3306 (MySQL) is publicly accessible - MySQL - Database server

      What to do: Immediately restrict access to MySQL using firewall or VPN

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

  3. Security headers

    Security headers are instructions your web server sends to every visitor’s browser. Missing ones leave visitors more exposed to attacks such as clickjacking and injected scripts.

    • High

      Missing Strict-Transport-Security header

      Forces HTTPS connections

      What to do: Add "Strict-Transport-Security: max-age=31536000; includeSubDomains; preload"

      • CWE-319
      • OWASP A04:2025
      • ASVS V3.4.1
    • High

      Missing X-Frame-Options header

      Prevents clickjacking attacks

      What to do: Add "X-Frame-Options: DENY" or "X-Frame-Options: SAMEORIGIN"

    • High

      Missing Content-Security-Policy header

      Controls resources the browser is allowed to load

      What to do: Implement a Content-Security-Policy appropriate for your application

      • ASVS V3.4.3
      • OWASP Secure Headers: OWASP Secure Headers Project recommends Content-Security-Policy: default-src 'self'; form-action 'self'; base-uri 'self'; object-src 'none';…

Need hands-on remediation? Email guard@offseq.com

Keep watching alopharm.com

This scan found 23 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
0
Security headers
15
Email security
70
DNS health
75
Network security
0
GDPR outside view
35
Average
33

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet · found on this site
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company appears to operate in the pharmaceutical or healthcare sector, offering compliance and consulting services with a presence in multiple countries. The business model focuses on service provision to healthcare industry professionals. The website lacks detailed business information such as founding year or parent company, and no certifications or trust indicators are displayed. The absence of social media links and limited contact information suggests a low digital marketing footprint. The company may benefit from enhancing transparency and expanding its digital presence to improve market positioning and customer engagement.

Security posture

The website currently exhibits a low security maturity level. It lacks essential security headers and does not provide a privacy policy or cookie consent mechanism, which are critical for GDPR compliance. No incident response or vulnerability disclosure information is available. The absence of tracking and analytics scripts reduces privacy risks but also limits business intelligence capabilities. The site uses HTTPS, which is a positive security baseline. To improve security posture, the company should implement security headers, establish clear privacy and cookie policies, and provide incident response contacts. These steps will enhance compliance and build user trust.

Recommendations

  1. Implement a comprehensive privacy policy and cookie consent mechanism to ensure GDPR compliance.
  2. Add security headers such as Content-Security-Policy, X-Frame-Options, and X-Content-Type-Options to improve security posture.
  3. Establish a vulnerability disclosure policy and provide incident response contact information.
  4. Enhance SEO by removing noindex,nofollow meta tags and improving site content and metadata.
  5. Increase transparency by adding detailed business information, certifications, and social media links.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Alopharm
Description
Alopharm appears to be a company operating in the pharmaceutical or healthcare sector, offering services related to compliance, capabilities, and team expertise with a presence in multiple countries.
Key services
Compliance, Capabilities, Consulting, Team expertise
Content quality
basic
Branding
consistent

Technology

Stack
WordPress, Google Fonts, JavaScript
Performance
moderate
Mobile
basic
Accessibility
basic
SEO
poor

Security

Observed score
30/100

Analytics and tracking

Tracking level
minimal
Privacy practices
poor

Advertising

Transparency
poor

Site quality

Design
basic
User experience
basic
Content relevance
basic
Navigation
good
Professionalism
basic
Trustworthiness
moderate

Key observations

  1. Website uses WordPress CMS with custom theme
  2. No privacy or cookie policy found despite GDPR relevance
  3. Contact email present but no phone or physical address
  4. No visible security headers or advanced security measures
  5. No analytics or tracking scripts detected
  6. Website content is minimal and mostly informational
  7. No forms detected on the homepage
  8. No social media links found
  9. Meta robots tag set to noindex,nofollow, which may limit SEO and indexing
Technical notes

Notes

The website is built on WordPress CMS with a custom theme and uses Google Fonts for typography. The site loads JavaScript files for emoji support and theme functionality. Performance is moderate with basic mobile optimization and accessibility features. SEO is limited due to meta robots noindex,nofollow tags and lack of structured data or Open Graph metadata. No analytics or tracking technologies are detected, indicating minimal data collection. The site lacks advanced frameworks or platforms and does not expose any forms or user input fields. Technical debt appears low but modernization opportunities exist in SEO, accessibility, and security implementations.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with alopharm.com. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review alopharm.com.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.